Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Thermo Fisher Scientific; Agilent Technologies; Ontario Genomics Institute

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific said this week that it has established a grant program to award life science researchers more than $400,000 in RNA-interference reagents. The firm said that the Thermo Scientific Discovery Grant Program will include various siRNA, shRNA, and microRNA reagents from its Dharmacon and Open Biosystems RNAi technology portfolios.

The firm's grant program is open to both academic and commercial researchers, who may complete an application online at www.thermo.com/RNAiDiscovery. Applications for the grants will be accepted through Sep. 7.


Agilent Technologies said this week that Cold Spring Harbor Laboratory's Dolan DNA Learning Center has adopted the firm's 2100 Bioanalyzer system to teach high school students and teachers how to analyze DNA. Agilent said that it had previously donated an analyzer to DNALC, which subsequently purchased five more of the units for its teaching labs throughout New York City.


The Ontario Genomics Institute said this week that it is funding researchers developing prognostic genetic tests for hematopoietic stem cell transplants. The institute said that it is investing in the research, which is being conducted by Jayne Danska at the Hospital for Sick Children and John Dick and Jean Wang of the University Health Network, through its Pre-Commercialization Business Development Fund.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease, Study Finds

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer, Study Finds

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study says.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.